Next Innovative Clinical Research (Site 115) — Houston, Texas

Next Innovative Clinical Research (Site 115) is a clinical research site located in Houston, Texas, United States 77021.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Next Innovative Clinical Research (Site 115) has participated in 1 clinical trials.

Therapeutic areas: COVID-19.

Sponsors: Sagent Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Next Innovative Clinical Research (Site 115)?

Next Innovative Clinical Research (Site 115) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Next Innovative Clinical Research (Site 115) conducted?

Next Innovative Clinical Research (Site 115) has 1 clinical trials on record. Their work covers COVID-19.

Is Next Innovative Clinical Research (Site 115) accredited by Crixeo Health?

Next Innovative Clinical Research (Site 115) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Next Innovative Clinical Research (Site 115)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.